Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 76,636 | 79,024 | 66,433 | 50,752 | 45,651 |
| Depreciation Amortization | 8,810 | 9,044 | 8,826 | 8,474 | 7,916 |
| Income taxes - deferred | -1,039 | 814 | 4,111 | -1,599 | 3,194 |
| Accounts payable and accrued liabilities | -1,337 | 2,790 | -985 | 1,502 | -1,981 |
| Other Working Capital | 25,761 | 9,869 | 6,624 | 1,935 | 1,296 |
| Other Operating Activity | -3,646 | -2,648 | 7,796 | 9,044 | 10,032 |
| Operating Cash Flow | $105,185 | $98,893 | $92,805 | $70,108 | $66,108 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,411 | -8,004 | -8,278 | -10,609 | -4,159 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -42,694 |
| Purchase Of Investment | -3,871 | -8,643 | 0 | N/A | N/A |
| Sale Of Investment | 12,511 | N/A | 0 | N/A | N/A |
| Other Investing Activity | -4,495 | -4,942 | 0 | 0 | 0 |
| Investing Cash Flow | $-16,266 | $-21,589 | $-8,278 | $-10,609 | $-46,853 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 30,000 | N/A | 1,846 | 0 | 31,150 |
| Common Stock Issued | 10,970 | 454 | 309 | 39 | 12,005 |
| Common Stock Repurchased | -138,819 | -18,085 | -68,294 | -33,459 | -17,031 |
| Other Financing Activity | -15,166 | 7,466 | 1,597 | 48 | -35,701 |
| Financing Cash Flow | $-113,015 | $-10,165 | $-64,542 | $-33,372 | $-9,577 |
| Exchange Rate Effect | -2,121 | -635 | 501 | 4 | 886 |
| Beginning Cash Position | 137,343 | 70,839 | 50,353 | 24,222 | 13,658 |
| End Cash Position | 111,126 | 137,343 | 70,839 | 50,353 | 24,222 |
| Net Cash Flow | $-26,217 | $66,504 | $20,486 | $26,131 | $10,564 |
| Free Cash Flow | |||||
| Operating Cash Flow | 105,185 | 98,893 | 92,805 | 70,108 | 66,108 |
| Capital Expenditure | -20,421 | -8,051 | -8,432 | -10,643 | -4,192 |
| Free Cash Flow | 84,764 | 90,842 | 84,373 | 59,465 | 61,916 |